Health Ministry permits clinical trials for Ukrainian coronavirus drug

Health Ministry permits clinical trials for Ukrainian coronavirus drug

The Ministry of Health of Ukraine has permitted the start of clinical trials for Ukrainian drug intended for the treatment of coronavirus disease.

The relevant order of the Ministry of Health No.1038 of May 4 was published on the Ministry’s website.

"To permit clinical trials for a pharmaceutical product intended to implement measures aimed at preventing the occurrence and spread, localization and elimination of coronavirus disease (COVID-19)," the document reads.

According to the annex to the order, a "multicenter randomized study to evaluate the effectiveness of Bioven pharmaceutical product manufactured by the LLC Biopharma Plazma in the complex therapy of patients with pneumonia caused by coronavirus infection COVID-19 / SARS-CoV-2" will be conducted.

The trials will be conducted at Kyiv City Clinical Hospital No.17, Bila Tserkva City Hospital No. 3, Lviv Regional Infectious Diseases Clinical Hospital, Odesa City Infectious Diseases Hospital, and Kyiv City Clinical Hospital No.4.

As of May 6, Ukraine recorded 13,184 coronavirus cases, including 2,097 recoveries and 327 deaths.


Let’s get started read our news at facebook messenger > > > Click here for subscribe

While citing and using any materials on the Internet, links to the website not lower than the first paragraph are mandatory. In addition, citing the translated materials of foreign media outlets is possible only if there is a link to the website and to the website of a foreign media outlet. Citing and using materials in offline media, mobile apps, Smart TV are allowed only with written permission from Ukrinform. News and publications marked as "Advertisement" and "PR" and articles in the section "Releases" include promoted content, and an advertiser is responsible for the content.

© 2015-2021 Ukrinform. All rights reserved.

Website design Studio Laconica

Extended searchHide extended search
By period: